# The Vascular Effects of Exenatide Versus Metformin in Patients With Pre-Diabetes

> **NCT00546728** · PHASE4 · COMPLETED · sponsor: **St. Paul Heart Clinic** · enrollment: 50 (actual)

## Conditions studied

- Impaired Glucose Tolerance

## Interventions

- **DRUG:** Exenatide
- **DRUG:** Metformin

## Key facts

- **NCT ID:** NCT00546728
- **Lead sponsor:** St. Paul Heart Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-10
- **Primary completion:** 2011-07
- **Final completion:** 2011-07
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2013-11-08

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00546728

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00546728, "The Vascular Effects of Exenatide Versus Metformin in Patients With Pre-Diabetes". Retrieved via AI Analytics 2026-08-18 from https://api.ai-analytics.org/clinical/NCT00546728. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*